Charles River Laboratories International, Inc. (NYSE: CRL)
47 Days left to seek lead plaintiff status.
Contact a Lawyer Now
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until July 18, 2023 to file lead plaintiff applications in a securities class action lawsuit against Charles River Laboratories International, Inc. (NYSE: CRL).
Charles River and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
On February 22, 2023, pre-market, the Company disclosed that it had received a subpoena from the U.S. Department of Justice relating to an ongoing investigation in conjunction with the U.S. Fish and Wildlife Service into the supply chain and illegal importation of non-human primates for research, and that the Company voluntarily suspended shipments of primates from Cambodia, which would negatively impact its earnings for the year and would reduce revenue growth by 200 basis points to 400 basis points.
On this news, shares of Charles River fell $24.51, or 10%, to close at $219.09 per share on February 22, 2023, on unusually heavy trading volume.
If you purchased securities of Charles River and would like to discuss your legal rights and how this case might affect you and your right to recover for your economic loss, you may, without obligation or cost to you, contact KSF Managing Partner Lewis Kahn toll-free at 1-877-515-1850 or via email (email@example.com), or fill out the form on this page.
The case is Coleman v. Charles River Laboratories International, Inc., et al., No. 23-cv-11132.